Skip to main content

FARALLON CAPITAL MANAGEMENT LLC

Position in BBIO — BridgeBio Pharma, Inc.

CIK 909661 SAN FRANCISCO, CA

Position in BBIO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$695,479,282
+$7,186,848 QoQ
Shares Held
9,365,463
+4.1% QoQ
Ownership
4.78%
of shares outstanding
% of Portfolio
4.64%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

FARALLON CAPITAL MANAGEMENT LLC holds $5,160,870,541 across 65 Biotechnology names. BBIO ranks #2 (13.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 BBIO
BridgeBio Pharma, Inc.
This page
9,365,463 $695,479,282

All Filings in BBIO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $695,479,282 9,365,463
2025-12-31 $688,292,434 8,998,463
2025-09-30 $425,492,480 8,192,000
2025-06-30 $341,122,000 7,900,000
2025-03-31 $198,120,670 5,731,000
2024-12-31 $115,110,800 4,195,000
2024-09-30 $44,478,620 1,747,000
2023-12-31 $242,220 6,000